Immuneering
IMRX
#9556
Rank
โ‚น4.06 B
Marketcap
โ‚น113.28
Share price
-2.68%
Change (1 day)
-35.85%
Change (1 year)

Revenue for Immuneering (IMRX)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Immuneering from 2020 to 2024

Annual revenue

Year Revenue Change
2024 N/A
2023 N/A-100%
2022 โ‚น26.22 M-83.06%
2021 โ‚น0.15 B-8.42%
2020 โ‚น0.16 B